The Relationship Between Hepatitis B Surface Antibody Levels and the Levels of Serum Glutamic Pyruvic Transaminase, Serum Glutamic Oxaloacetic Transaminase, and Total Bilirubin
DOI:
https://doi.org/10.53770/medica.v6i2.492Keywords:
Hepatitis B, SGOT, SGPT, BilirubinAbstract
Hepatitis B virus is a disease that can impair other functions of the liver. This study aims to determine the relationship between Hepatitis B antibody levels and the levels of SGOT (Serum Glutamic Oxaloacetic Transaminase), SGPT (Serum Glutamic Pyruvic Transaminase), and bilirubin. A quantitative analytic study with a cross-sectional approach was conducted. Data collection involved primary data in the form of hepatitis B serum samples and secondary data including SGOT levels, SGPT levels, bilirubin levels, age, gender, and medical history. The results showed a significant and inverse relationship between Hepatitis B antibody levels and SGOT levels, with a Sig. (2-tailed) value of 0.029 (<0.05) and a negative correlation coefficient of -0.627. Similarly, there was a significant and inverse relationship between Hepatitis B antibody levels and SGPT levels, with a Sig. (2-tailed) value of 0.003 (<0.05) and a negative correlation coefficient of -0.616. However, there was no significant relationship between Hepatitis B antibody levels and bilirubin levels, as indicated by a Sig. (2-tailed) value of 0.809 (>0.05), although the correlation was positive (correlation coefficient = 0.078). In conclusion, Hepatitis B antibody levels show a significant negative correlation with SGOT and SGPT levels, while the correlation with bilirubin levels is positive but not statistically significant.
References
Abdalah, R. S. (2020). Evaluation Of Hepatitis B Viral Antigen And Liver Enzymes in Chronic Hepatitis B Patients. Doctoral Dissertation, Sulaimani Polytechnic University.
Ahdi, M. N. W. (2023). Pemeriksaan kadar sgot dan sgpt pada penderita hepatitis b di RSUD Jombang. Diploma Thesis, Institut Teknologi Sains dan Kesehatan Insan Cendekia Medika Jombang.
Al Waali, M. H., Nurmalasari, Y., Fitriani, D., & Zulfian, Z. (2023). Gambaran Nilai Laboratorium SGOT dan SGPT Pada Penderita Hepatitis B Di Rsud Abdul Moeloek Lampung Tahun 2021. Medical Profession Journal of Lampung, 13(6), 1013-1019.
Badan Penelitian dan Pengembangan Kesehatan. (2018). Laporan Nasional Riskesdas 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.
Badriyya, E., & Srangenge, Y. (2023). Serologi imunologi. Padang: Universitas Andalas
Corral‐Jara, K. F., Trujillo‐Ochoa, J. L., Realpe, M., Panduro, A., Roman, S., & Fierro, N. A. (2015). Rethinking the immune properties of bilirubin in viral hepatitis: from bench to bedside. Clinical & Translational Immunology, 4(12), e54. https://doi.org/10.1038/cti.2015.37.
Di Lello, F. A., Martínez, A. P., & Flichman, D. M. (2022). Insights into induction of the immune response by the hepatitis B vaccine. World journal of gastroenterology, 28(31), 4249.4249–4262. https://doi.org/10.3748/wjg.v28.i31.424.
Du, M., Zhang, S., Xiao, L., Xu, Y., Liu, P., Tang, Y., ... & Yao, P. (2016). The relationship between serum bilirubin and elevated fibrotic indices among HBV carriers: a cross-sectional study of a Chinese population. International journal of molecular sciences, 17(12), 2057. https://doi.org/10.3390/ijms17122057.
Geni, L., & Yahya, E. M. (2022). Gambaran Jumlah Trombosit dengan Kadar SGOT dan SGPT Pada Penderita Hepatitis B. Anakes: Jurnal Ilmiah Analis Kesehatan, 8(1), 30-38. https://doi.org/10.37012/anakes.v8i1.707
Gunawan, L. S., & Herawati, R. (2017). Uji Kadar Anti-HBs pada Balita Penerima Imunisasi Dasar. Biomedika, 10(2), 1-10. https://doi.org/10.31001/biomedika.v10i2. 269.
Handayani, R. (2020). Penyakit Yang Dapat Ditularkan Melalui Darah Dan Seksual. Jakarta Barat: Universitas Esa Unggul.
Handojo, I. (2014). Imunologi Terapan pada Beberapa Penyakit Infeksi. Surabaya: Airlangga University Press.
Hidayati, T. (2019). Uji Aktivitas Hepatoprotektor tepung Kedelai dalam Mencegah Peningkatan Kadar SGOT dan SGPT Tikus Wistar yang Diinduksi Diazinon. Skripsi, Universitas Jember.
Jackson, K., Locarnini, S., & Gish, R. (2018). Diagnostics of hepatitis B virus: standard of care and investigational. Clinical liver disease, 12(1), 5-11. https://doi.org/10.1002/cld.729
Kamil, Raudah, S., Kamil, M. & Wahid, R.S.A. (2021). Pemeriksaan Alpha-Fetoprotein (AFP) Metode ELFA Menggunakan Alat Vidas Biomerieux Di Laboratorium Immuno Serologi RSUD Abdul Wahab Sjahranie Samarinda. Jurnal Teknologi Laboratorium Medik Borneo, 1(1), 42-45.
Kasih, T., & Hapsari, R. (2017). Profil anti-HBS sebagai penanda kekebalan terhadap infeksi virus hepatitis B pada mahasiswa kedokteran. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal), 6(2), 1279-1289.
Kementerian Kesehatan Republik Indonesia. (2017). Situasi Penyakit Hepatitis B. Jakarta: Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan Republik Indonesia. (2020). RAN Pengendalian Hepatitis 2020-2024. Jakarta: Kementerian Kesehatan Republik Indonesia.
Khairani, N. R., Kurniawan, M. R., & Dewi, A. P. (2022). Differences of SGOT-SGPT Levels in Serum and EDTA Plasma in Hepatitis B Patients. Jurnal Ilmu dan Teknologi Kesehatan, 9(2), 253-260.
Khumaedi, A. I., Gani, R. A., & Hasan, I. (2016). Pencegahan transmisi vertikal hepatitis B: fokus pada penggunaan antivirus antenatal. Jurnal Penyakit Dalam Indonesia, 3(4), 225-231. https://doi.org/10.7454/jpdi.v3i4.57.
Masriadi, M. (2014). Epedimiologi Penyakit Menular. Depok: Raja Grafindo Persada. Rosida, A. (2016). Pemeriksaan laboratorium penyakit hati. Berkala Kedokteran, 12(1), 123-131.
Philips, C. A., Ahamed, R., Abduljaleel, J. K., Rajesh, S., Augustine, P., Abduljaleel, J., & Rajesh, S. (2021). Critical updates on chronic hepatitis B virus infection in 2021. Cureus, 13(10). https://doi.org/10.7759/cureus.19152.
Puspita, T., & Kamilah, I. (2016). Pengkajian penggunaan obat pada pasien hepatitis B di Rumah Sakit Umum Pemerintah Kabupaten Garut. Jurnal Ilmiah Farmako Bahari, 7(1), 36-41.
Smalls, D. J., Kiger, R. E., Norris, L. B., Bennett, C. L., & Love, B. L. (2019). Hepatitis B virus reactivation: risk factors and current management strategies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 39(12), 1190-1203. https://doi.org/10.1002/phar.2340.
Saulahirwan, R., Sinay, H., & Karuwal, R. L. (2023). Transaminase Enzyme and Liver Histopatological Structure of Mice Facing to Smoke Cigarettes After Administerred with Enhalus acoroides Peel Extract. Biosaintifika: Journal of Biology & Biology Education, 15(1), 97-104.
Selung, R., Wasliah, I., & Pratiwi, E.A. (2017). Gambaran Hasil Pemeriksaan BilirubinTotal Pada Pasien Hepatitis. 5(1), 56–60.
Sihombing, J. R., & Gultom, E. (2016). Pemeriksaan Serum Glutamic Pyruvic Transaminase (SGPT) pada penderita hepatitis B yang mengkonsumsi obat lebih dari 1 bulan di RSUP H. Adam malik Medan tahun 2016. Jurnal Analis Laboratorium Medik, 1(2), 1-6.
Sridanti, R. (2019). Gambaran Aktivitas Enzim SGOT Dan SGPT Pada Paien Hepatitis Di RSUD Bandung. Universitas Perintis Indonesia.
Sugiyono, S. (2017). Metode Penelitian Kuantitatif, Kualitatif dan R&D. Bandung: CV. Alfabeta.
Tan, A., Koh, S., & Bertoletti, A. (2015). Immune response in hepatitis B virus infection. Cold Spring Harbor perspectives in medicine, 5(8), a021428. https://doi.org/10.1101/cshperspect.a021 428.
Tong, S., Li, J., Wands, J. R., & Wen, Y. M. (2013). Hepatitis B virus genetic variants: biological properties and clinical implications. Emerging microbes & infections, 2(1), 1-11. https://doi.org/10.1038/emi.2013.10.
Xie, S., Wei, S., Ma, X., Wang, R., He, T., Zhang, Z., ... & Zhao, Y. (2023). Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. Frontiers in Pharmacology, 14, 1173542.https://doi.org/10.3389/fphar.2023.1173 542.
WHO. (2023). Hepatitis B. World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 MEDICA (International Medical Scientific Journal)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
